Article Details
Retrieved on: 2024-11-09 00:00:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A handful of these BBB-penetrating candidates are being developed, but so far only one—Roche's trontinemab—has made its way into clinical trials.
Article found on: www.alzforum.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here